Published in:
01-03-2022 | Nephrectomy | Original Article
Outcomes after 20 years of experience in minimally invasive living-donor nephrectomy
Authors:
Mireia Musquera, Lluis Peri, Maurizio D’Anna, Tarek Ajami, Maria José Ribal, Antoni Vilaseca, Ignacio Revuelta, Ricardo Álvarez-Vijande, Ana Palacios, Fritz Diekmann, Conchita Monsalve, Beatriz Tena, Laura Izquierdo, Raul Martos, David Paredes, Joan Beltran, Federico Oppenheimer, Antonio Alcaraz
Published in:
World Journal of Urology
|
Issue 3/2022
Login to get access
Abstract
Introduction
The transperitoneal laparoscopic approach is considered the gold standard technique for living kidney donation. Other accepted laparoscopic techniques include the retroperitoneal approach, natural orifice transluminal endoscopic surgery (NOTES)-assisted, laparo-endoscopic single-site surgery (LESS), with excellent results in the donor and graft. Many studies have compared these techniques with open ones. Our objective is to describe our experience and results in minimally invasive living-donor nephrectomies (MILDN): laparoscopic, NOTES-assisted, and LESS since their introduction in March 2002.
Materials and methods
We conducted a retrospective observational study of donors undergoing MILDN between March 2002 and March 2020.
Results
A total of 714 MILDNs were performed at our centre. All were completed, except for one, because of recipient death. The conventional laparoscopic approach was used in 541 cases (75.88%), NOTES in 116 (16.9%), LESS in 55 (7.7%), and one mini open (0.14%). Two-thirds of the donors were females (478 cases). The mean donor age was 52.87 years (SD 10.93). Six donors (0.8%) were diagnosed beforehand with a small renal mass, which was removed before transplantation in bench surgery. The right kidney was removed in 17.8% of cases. Warm ischaemia time was higher in the NOTES and LESS groups. We had eight conversions. The global intraoperative and postoperative complication rates were 6.8% and 4.9%, respectively. None of the donors developed renal disease during follow-up (mean 3.68 years). Five-year recipient and graft survival rates were 98.8% and 96.8%, respectively.
Conclusions
MILDN techniques are safe for donors and grafts, with low complication.